Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial. (Record no. 18920339)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02005 a2200553 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250515173409.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 200911s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1520-6394 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1002/da.20589 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Akhondzadeh, Shahin |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20091123 |
245 00 - TITLE STATEMENT | |
Title | Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Depression and anxiety |
Date of publication, distribution, etc. | 2009 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 607-11 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Celecoxib |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cyclooxygenase 2 Inhibitors |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Depressive Disorder, Major |
General subdivision | diagnosis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Diagnostic and Statistical Manual of Mental Disorders |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Dinoprostone |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Double-Blind Method |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Administration Schedule |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Therapy, Combination |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Fluoxetine |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Interleukin-6 |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Prospective Studies |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pyrazoles |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Selective Serotonin Reuptake Inhibitors |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Severity of Illness Index |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Sulfonamides |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Surveys and Questionnaires |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Young Adult |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Jafari, Sara |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Raisi, Firoozeh |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Nasehi, Abbas Ali |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ghoreishi, Aboulfazl |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Salehi, Bahman |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mohebbi-Rasa, Soodeh |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Raznahan, Maedeh |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kamalipour, Abbas |
773 0# - HOST ITEM ENTRY | |
Title | Depression and anxiety |
Related parts | vol. 26 |
-- | no. 7 |
-- | p. 607-11 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1002/da.20589">https://doi.org/10.1002/da.20589</a> |
Public note | Available from publisher's website |
No items available.